Evolution, control and success of combination therapy with Ampicilin-sulbactam/Ceftazidime-Avibactam during a Carbapenem-Resistant Acinetobacter baumannii outbreak in burn Intensive Care Unit.
Eur J Clin Microbiol Infect Dis
; 43(7): 1453-1459, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38676856
ABSTRACT
We present our findings on interpatient transmission, epidemic control measures, and the outcomes of a series of ten critically ill burn patients who were either colonized or infected with carbapenem-resistant Acinetobacter baumannii (CRAB). None of the five infected patients achieved clinical cure, and all experienced relapses. Microbiological failure was observed in 40% of the infected patients. The isolated CRAB strains were found to carry blaOXA-23 and armA resistance genes. Despite the lack of clinical cure, all five infected patients survived and were discharged from the Burn Intensive Care Unit.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Infecções por Acinetobacter
/
Sulbactam
/
Carbapenêmicos
/
Ceftazidima
/
Surtos de Doenças
/
Acinetobacter baumannii
/
Combinação de Medicamentos
/
Compostos Azabicíclicos
/
Unidades de Terapia Intensiva
/
Antibacterianos
Idioma:
En
Revista:
Eur J Clin Microbiol Infect Dis
Assunto da revista:
DOENCAS TRANSMISSIVEIS
/
MICROBIOLOGIA
Ano de publicação:
2024
Tipo de documento:
Article
País de afiliação:
França